Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by alphatradron Oct 02, 2018 9:23am
101 Views
Post# 28727962

Own, increase, & let it be, such a winner. Sell if you wish.

Own, increase, & let it be, such a winner. Sell if you wish.

* TETRA BIO-PHARMA ANNOUNCES PPP002 PROGRAM UPDATE FOLLOWING TYPE B MEETING WITH U.S. FDA

* TETRA BIO PHARMA INC - SHORTER REGULATORY PATHWAY CONFIRMED BY FDA AND POTENTIAL FOR SCHEDULE 3 CLASSIFICATION

* TETRA BIO PHARMA INC - FDA CONFIRMED ELIGIBILITY OF 505(B)(2) REGULATORY PATHWAY FOR PRODUCT PPP002

* TETRA BIO PHARMA INC - ANTICIPATES SUBMITTING A NEW DRUG APPLICATION TO COMMERCIALIZE PPP002 IN Q1 2019

* TETRA BIO PHARMA INC - IN MEETING, FDA ALSO PROVIDED CLEAR GUIDANCE ON SAFETY AND DRUG ABUSE DATA REQUIREMENTS FOR NEW DRUG APPLICATION

<< Previous
Bullboard Posts
Next >>